Published online before print October 19, 2006, doi: 10.1161/01.RES.0000250259.66683.f5
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 26, 2006
Revised on September 19, 2006
Accepted on October 5, 2006
Genetic Ablation of Angiotensinogen in the Subfornical Organ of the Brain Prevents the Central Angiotensinergic Pressor Response
Puspha Sinnayah ;
From the Departments of Anatomy and Cell Biology (P.S., E.L., R.V.S, R.L.D.), Physiology and Biophysics (K.S., C.D.S.), Internal Medicine (K.S., C.D.S.), Radiation Oncology (Free Radical and Radiation Biology Program [R.L.D.]), and the Cardiovascular Center (R.V.S., C.D.S., R.L.D.), Roy J. and Lucille A. Carver College of Medicine, the University of Iowa, Iowa City.
* To whom correspondence should be addressed. E-mail: robin.davisson{at}cornell.edu.
The subfornical organ (SFO) of the brain has long been considered a critical integrating center for the cardiovascular actions of the renin-angiotensin system (RAS). Early reports of angiotensin II (Ang II) immunoreactivity in the SFO and its neural projections to downstream cardiovascular nuclei raised the possibility that Ang II is produced locally and functions as a putative neurotransmitter in these circuits. However, evidence of functionally significant de novo synthesis of Ang II in the SFO has been lacking. Here, implementing spatiotemporally restricted gene ablation by way of the Cre recombinase/loxP system, we provide the first direct evidence that the local RAS in the SFO has a critical role in blood pressure regulation. Using a transgenic mouse harboring an angiotensinogen (AGT) gene modified for Cre-mediated deletion (hAGTflox), in combination with gene transfer of an adenovirus encoding Cre targeted to the SFO, we show that deletion of the Ang II substrate in this brain region nearly abolishes the pressor and bradycardic effects of renin infused in the CNS. Immunohistochemical analyses verified intense and restricted expression of Cre in the SFO, which paralleled the decrease in AGT expression selectively in this site. Further physiological studies confirmed the integrity of central angiotensinergic and nonangiotensinergic cardiovascular response systems in the Cre-treated mice. In addition to establishing that AGT expression in the SFO and its local conversion to Ang II has a profound effect on blood pressure, this study provides proof-of-principle of the utility of this approach for dissecting the brain RAS and other complex systems in CNS cardiovascular circuits.
Key words: renin-angiotensin system • hypertension • Cre recombinase • transgenic mice • adenovirus
This article has been cited by other articles:
 |
|
 |
|
  J. R. Peterson, M. A. Burmeister, X. Tian, Y. Zhou, M. R. Guruju, J. A. Stupinski, R. V. Sharma, and R. L. Davisson Genetic Silencing of Nox2 and Nox4 Reveals Differential Roles of These NADPH Oxidase Homologues in the Vasopressor and Dipsogenic Effects of Brain Angiotensin II Hypertension, November 1, 2009; 54(5): 1106 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lazartigues, P. Sinnayah, G. Augoyard, C. Gharib, A. K. Johnson, and R. L. Davisson Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1539 - R1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Grobe, D. Xu, and C. D. Sigmund An Intracellular Renin-Angiotensin System in Neurons: Fact, Hypothesis, or Fantasy Physiology, August 1, 2008; 23(4): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Ferreira and M. K. Raizada Aminopeptidase A: Could It Be a Novel Target for Neurogenic Hypertension? Hypertension, May 1, 2008; 51(5): 1273 - 1274. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Feng, X. Yue, H. Xia, S. M. Bindom, P. J. Hickman, C. M. Filipeanu, G. Wu, and E. Lazartigues Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II-Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation Circ. Res., March 28, 2008; 102(6): 729 - 736. [Abstract] [Full Text] [PDF]
|
|